FDA and FTC Compliance for Skincare and Personal Care Brands: From Cosmetic to OTC Drug Claims

Skincare and personal care is one of the most aggressively policed categories on Amazon, in retailer claim reviews, and in class-action litigation. The FTC and FDA both have jurisdiction — FTC on advertising and substantiation, FDA on labeling and on the cosmetic-vs-drug distinction — and the lines between a cosmetic, an OTC drug, and a dietary supplement (for ingestible beauty) move quickly. Brands that publish a single overreach can lose a retail listing, eat a takedown on TikTok Shop, and trigger a class-action filing in the same quarter. This guide is what every skincare, beauty, and personal care brand should understand before publishing a claim, finalizing a label, or sending an influencer brief. The cosmetic vs. drug distinction FDA defines a cosmetic as a product intended to cleanse, beautify, promote attractiveness, or alter appearance without affecting structure or function of the body. A drug is a product intended to diagnose, cure, treat, prevent, or mitigate disease, or to affect structure or function. Where intent crosses the line, FDA can classify a product as a drug — even if the marketing never uses the word. Cosmetic (allowed without monograph): "Improves the appearance of fine lines," "hydrates and softens skin," "reduces the look of dark spots." OTC drug (requires monograph compliance): "Treats acne," "prevents sunburn" (sunscreens), "protects against tooth decay" (anti-cavity), "treats eczema" (anti-itch). Off-limits without drug approval: "Cures rosacea," "reverses photoaging at the cellular level," "treats melasma." FTC substantiation for cosmetic and personal care claims The FTC requires "competent and reliable scientific evidence" for any objective product claim. For a quantitative cosmetic claim ("reduces wrinkle depth by 27%"), the agency expects a controlled human study using validated, instrumented endpoints — dermatologist grading plus an instrument like a 3D imaging system or corneometer. The study must be on the finished product, in a target population that matches the marketed buyer, and the claim must match the measured outcome. "Up to 27%" is acceptable only if the cohort actually reached it. Common pitfalls in skincare and beauty claims Borrowing an ingredient study (e.g., a published retinol study) and applying the result to your finished formulation. Running a study in 12 women in their 20s and claiming results for "all skin types and ages." Stacking superlatives ("the most effective," "clinically proven") without head-to-head data. Using before/after photos that combine product results with retouching, makeup, or lighting changes. Influencer copy that drifts into drug claims ("cleared my eczema," "healed my acne") without controlling the brief. Building a defensible skincare evidence file A defensible substantiation file for a cosmetic or personal care claim contains: (1) the IRB-approved protocol, (2) the finished-product clinical study report with dermatologist grading and at least one instrumented endpoint, (3) the standardized before/after photo set, (4) the validated subject self-assessment data, (5) the influencer brief and approval workflow showing claim-control, and (6) a claim-substantiation matrix mapping every label and ad claim to the specific data point that supports it. Citruslabs builds substantiation files in this exact format for skincare, beauty, suncare, haircare, and topical wellness brands — ready for retailer submission, Amazon Brand Registry, and FTC inquiry.